Lv0
0 积分 2024-09-01 加入
NK Cell Phenotype Is Associated With Response and Resistance to Daratumumab in Relapsed/Refractory Multiple Myeloma
1个月前
已完结
Regulation of CD38 on Multiple Myeloma and NK Cells by Monoclonal Antibodies
1个月前
已完结
Pembrolizumab plus single-fraction radiotherapy for patients with relapsed or refractory multiple myeloma
2个月前
已完结
MEF2C regulates NK cell effector functions through control of lipid metabolism
2个月前
已完结
Pembrolizumab and low-dose, single-fraction radiotherapy for patients with relapsed or refractory multiple myeloma: a prospective, single-centre, single-group, open-label, phase 2 pilot trial in the USA
2个月前
已完结
皖公网安备34019202002308
